Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in PerinatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Persistent pulmonary hypertension of the newborn in late preterm and term infants in California.Pediatrics. 2017; 139: e20161165
- A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure.Pediatrics. 2004; 113: 559-564
- Role of the pulmonary circulation in the distribution of human fetal cardiac output during the second half of pregnancy.Circulation. 1996; 94: 1068-1073
- Regulation of the pulmonary circulation in the fetus and newborn.Physiol Rev. 2010; 90: 1291-1335
- Developmental biology of the pulmonary circulation.Paediatr Respir Rev. 2005; 6: 35-43
- Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth.Am J Physiol. 1990; 259: H1921-H1927
- Role of oxidative phosphorylation and ATP release in mediating birth-related pulmonary vasodilation in fetal lambs.Am J Physiol Heart Circ Physiol. 2002; 283: H1600-H1608
- Purine nucleotides contribute to pulmonary vasodilation caused by birth-related stimuli in the ovine fetus.Am J Physiol. 1997; 272: H2377-H2384
- Revisiting the kinetics of nitric oxide (NO) binding to soluble guanylate cyclase: the simple NO-binding model is incorrect.Proc Natl Acad Sci U S A. 2002; 99: 12097-12101
- Pulmonary soluble guanylate cyclase, a nitric oxide receptor, is increased during the perinatal period.Am J Physiol. 1997; 272: L400-L406
- Paracrine role of soluble guanylate cyclase and type III nitric oxide synthase in ovine fetal pulmonary circulation: a double labeling immunohistochemical study.Histochem Cell Biol. 2003; 119: 125-130
- High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors.Biochem Biophys Res Commun. 2005; 334: 930-938
- Decreased endothelial nitric oxide synthase expression and function contribute to impaired mitochondrial biogenesis and oxidative stress in fetal lambs with persistent pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2016; 310: L40-L49
- Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension.Am J Physiol. 1997; 272: L1005-L1012
- Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus.Am J Physiol. 1997; 272: L1013-L1020
- Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension.Pediatr Res. 1998; 44: 338-343
- Altered prostanoid metabolism contributes to impaired angiogenesis in persistent pulmonary hypertension in a fetal lamb model.Pediatr Res. 2015; 77: 455-462
- Endothelin B receptor blockade attenuates pulmonary vasodilation in oxygen-ventilated fetal lambs.Biol Neonate. 2004; 86: 155-159
- Overexpression of endothelin-1 and enhanced growth of pulmonary artery smooth muscle cells from fawn-hooded rats.Am J Physiol. 1996; 270: L101-L109
- Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2.J Cardiovasc Pharmacol. 1993; 22: S328-S331
- Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension.J Pediatr. 1993; 123: 109-114
- Pulmonary hypertension and vascular abnormalities in bronchopulmonary dysplasia.Clin Perinatol. 2015; 42: 839-855
- The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 year.J Pediatr. 2018; 203: 218-224.e3
- Pulmonary hypertension in bronchopulmonary dysplasia.Pediatr Res. 2021; 89: 446-455
- Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.Pediatr Res. 2009; 66: 539-544
- Nitric oxide for respiratory failure in infants born at or near term.Cochrane Database Syst Rev. 2000; 1: CD000399
- Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.N Engl J Med. 1997; 336: 605-610
- Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.N Engl J Med. 2000; 342: 469-474
- Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.N Engl J Med. 1997; 336: 597-604
- Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure.J Perinatol. 2013; 33: 944-949
- Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide.Pediatr Pulmonol. 2001; 32: 14-19
- Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS).Pediatrics. 1997; 99: 838-845
- Evaluation of variability in inhaled nitric oxide use and pulmonary hypertension in patients with congenital diaphragmatic hernia.JAMA Pediatr. 2016; 170: 1188-1194
- Inhaled nitric oxide is associated with improved oxygenation in a subpopulation of infants with congenital diaphragmatic hernia and pulmonary hypertension.J Pediatr. 2020; 219: 167-172
- Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.Am J Physiol Lung Cell Mol Physiol. 2011; 301: L755-L764
- Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.Respir Physiol Neurobiol. 2010; 174: 272-281
- Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study.Pediatrics. 2006; 117: 1077-1083
- The use of sildenafil in persistent pulmonary hypertension of the newborn.Am J Perinatol. 2010; 27: 225-230
- Effect of early adjunctive use of oral sildenafil and inhaled nitric oxide on the outcome of pulmonary hypertension in newborn infants. A feasibility study.J Neonatal Perinatal Med. 2016; 9: 251-259
- Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension.J Pediatr. 2009; 155: 841,e1
- Efficacy and safety of IV sildenafil in the treatment of newborn infants with, or at risk of, persistent pulmonary hypertension of the newborn (PPHN): a multicenter, randomized, placebo-controlled trial.J Pediatr. 2021; 237: 154-161.e3
- Prostacyclin treatment for persistent pulmonary hypertension of the newborn.Pediatr Cardiol. 1997; 18: 3-7
- Safety of epoprostenol and treprostinil in children less than 12 months of age.Pulm Circ. 2013; 3: 862-869
- Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.J Pediatr. 2002; 141: 830-832
- Inhaled epoprostenol therapy for pulmonary hypertension: improves oxygenation index more consistently in neonates than in older children.Pulm Circ. 2012; 2: 61-66
- Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn.Intensive Care Med. 1997; 23: 1275-1278
- Aerosolised prostacyclin for pulmonary hypertension in neonates.Arch Dis Child Fetal Neonatal Ed. 1994; 71: F214-F216
- Inhaled epoprostenol for pulmonary hypertension treatment in neonates: a 12-year experience.Am J Perinatol. 2019; 36: 1142-1149
- Inhaled iloprost as a first-line therapy for persistent pulmonary hypertension of the newborn.Neonatal Med. 2019; 26: 191-197
- Oral sildenafil and inhaled iloprost in the treatment of pulmonary hypertension of the newborn.Pediatr Pulmonol. 2014; 49: 1205-1213
- Iloprost drug delivery during infant conventional and high-frequency oscillatory ventilation.Pulm Circ. 2016; 6: 63-69
- Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study.Klin Padiatr. 2008; 220: 66-69
- Inhaled iloprost in preterm infants with severe respiratory distress syndrome and pulmonary hypertension.Am J Perinatol. 2014; 31: 321-326
- Effectiveness and safety of intravenous iloprost for severe persistent pulmonary hypertension of the newborn.Indian Pediatr. 2013; 50: 934-938
- Treprostinil for persistent pulmonary hypertension of the newborn, with early onset sepsis in preterm infant: 2 Case reports.Medicine (Baltimore). 2017; 96: e7303
- Transitioning from intravenous to subcutaneous prostacyclin therapy in neonates with severe pulmonary hypertension.J Pediatr Pharmacol Ther. 2020; 25: 647-653
- Short-term treprostinil use in infants with congenital diaphragmatic hernia following repair.J Pediatr. 2015; 167: 762-764
- Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia.J Pediatr. 2018; 200: 44-49
- Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertension.Int Heart J. 2009; 50: 513-529
- Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension.Circ J. 2007; 71: 1829-1831
- Beraprost sodium for pulmonary hypertension with congenital heart disease.Pediatr Int. 2002; 44: 528-529
- Beraprost therapy in children with pulmonary hypertension secondary to congenital heart disease.Pediatr Cardiol. 2005; 26: 787-791
- Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review.Neonatology. 2011; 99: 32-37
- Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trial.Pediatr Res. 2004; 56: 579-585
- Inhaled PGE1 in neonates with hypoxemic respiratory failure: two pilot feasibility randomized clinical trials.Trials. 2014; 15: 486
- Milrinone for persistent pulmonary hypertension of the newborn.Cochrane Database Syst Rev. 2010; : CD007802
- Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide.Pediatr Crit Care Med. 2013; 14: 74-84
- Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn.J Crit Care. 2006; 21: 217-222
- Use of milrinone to treat cardiac dysfunction in infants with pulmonary hypertension secondary to congenital diaphragmatic hernia: a review of six patients.Neonatology. 2012; 102: 130-136
- The effect of milrinone on right and left ventricular function when used as a rescue therapy for term infants with pulmonary hypertension.Cardiol Young. 2016; 26: 90-99
- Efficacy of milrinone plus sildenafil in the treatment of neonates with persistent pulmonary hypertension in resource-limited settings: results of a randomized, double-blind trial.Paediatr Drugs. 2020; 22: 685-693
- A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn.J Perinatol. 2012; 32: 608-613
- Successful treatment of persistent pulmonary hypertension of the newborn with bosentan.Acta Paediatr. 2009; 98: 1683-1685
- Comparison of the efficacy of sildenafil alone versus sildenafil plus bosentan in newborns with persistent pulmonary hypertension.J Ayub Med Coll Abbottabad. 2018; 30: 333-336
- Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan.Eur J Pediatr. 2008; 167: 437-440
- Effect of bosentan therapy in persistent pulmonary hypertension of the newborn.Pediatr Neonatol. 2018; 59: 58-64
- Bosentan as adjunctive therapy for persistent pulmonary hypertension of the newborn: results of the randomized multicenter placebo-controlled exploratory trial.J Pediatr. 2016; 177: 90.e3
- Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension.Pediatr Res. 2008; 63: 67-72
- Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn.Pediatr Res. 2013; 73: 621-629
- Hydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn.Pulm Circ. 2014; 4: 71-81
- Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn.Am J Physiol Lung Cell Mol Physiol. 2012; 302: L595-L603
- The effect of steroids on the clinical course and outcome of neonates with meconium aspiration syndrome.J Trop Pediatr. 2007; 53: 8-12
- Oral l-citrulline malate in patients with idiopathic pulmonary arterial hypertension and Eisenmenger Syndrome: a clinical trial.J Cardiol. 2014; 64: 231-235
- Riociguat for the treatment of pulmonary arterial hypertension.N Engl J Med. 2013; 369: 330-340
- Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.Am J Physiol Lung Cell Mol Physiol. 2009; 297: L318-L325
- Activation of PPAR-γ ameliorates pulmonary arterial hypertension via inducing heme oxygenase-1 and p21(WAF1): an in vivo study in rats.Life Sci. 2014; 98: 39-43
- AMP-kinase dysfunction alters notch ligands to impair angiogenesis in neonatal pulmonary hypertension.Am J Respir Cell Mol Biol. 2020; 62: 719-731
- Evaluation and management of pulmonary hypertension in children with bronchopulmonary dysplasia.J Pediatr. 2017; 188: 24.e1
- Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease.J Pediatr. 2009; 154 (384.e1-4): 379-384
- Sildenafil for the treatment of pulmonary arterial hypertension in infants with bronchopulmonary dysplasia.Pediatr Cardiol. 2015; 36: 1255-1260
- Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?.J Perinatol. 2012; 32: 64-69
- Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.Pediatr Pulmonol. 2017; 52: 77-83
- Sildenafil therapy in bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective study of efficacy and safety.Eur J Pediatr. 2015; 174: 1109-1115
- EXPRESS: sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.Pulm Circ. 2019; (2045894019837875)
- Targeted therapy for pulmonary hypertension in premature infants.Children (Basel). 2020; 7: 97
- Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease.Pediatr Pulmonol. 2005; 40: 265-269
- Weaning of epoprostenol in a small infant receiving concomitant bosentan for severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia.Minerva Pediatr. 2006; 58: 491-494
- Subcutaneous treprostinil for pulmonary hypertension in chronic lung disease of infancy.Pediatrics. 2014; 134: e274-e278
- Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies.Pediatr Cardiol. 2008; 29: 1082-1086
- Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group.J Pediatr. 1998; 132: 40-47
- Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.J Perinatol. 2021; 41: 32-38
- Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.J Pediatr. 1997; 131: 55-62
Article info
Publication history
Published online: January 21, 2022
Footnotes
Conflicts of interest: Authors have no relevant financial conflicts of interest to disclose.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
